Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)

NCT: NCT07120945 · ACTIVE_NOT_RECRUITING

NCT IDNCT07120945
StatusACTIVE_NOT_RECRUITING
Start Date2025-08-28
Completion2031-05
SponsorMedtronic - MITG (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this research is to evaluate the safety and performance of the investigational Medtronic Hugo™ Robotic Assisted Surgery (RAS) system when used during hysterectomy procedures, including patients being treated for cancer.

Frequently Asked Questions

What is Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)?

Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology) is a clinical trial registered under NCT07120945. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07120945?

The current status of NCT07120945 (Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)) is: ACTIVE_NOT_RECRUITING.

When did Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology) start?

Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology) started on 2025-08-28.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑